Quotes

Back To Menu

Tata India Pharma & Healthcare Fund (IDCW) Equity - Pharma
INVEST

Plan: OPEN | Option: Dividend | Meeta Shetty

20 Dec 24 | 12:00 AM

30.82 0.18 (0.58%)

  • Outperforms

    42.34%

    Return (1Y)

    beaten Nifty Pharma TRI by 1.83%

  • Less Volatile

    0.83%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.12%

  • Not so consistent

    6/12

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (IDCW), has beaten by 1.83% (CAGR difference)

42.34%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

22 Dec 2023

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (IDCW) is Lower than by -0.12%

0.83%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 6 out of Last 12 Months, i.e 50% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition